Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
Titel:
Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
Auteur:
Kerstjens, Huib A M Maspero, Jorge Chapman, Kenneth R van Zyl-Smit, Richard N Hosoe, Motoi Tanase, Ana-Maria Lavecchia, Catherine Pethe, Abhijit Shu, Xu D'Andrea, Peter